DEPOSIT AGREEMENT by and amongDeposit Agreement • April 3rd, 2018 • Nightstar Therapeutics PLC • Biological products, (no disgnostic substances) • New York
DEPOSIT AGREEMENT, dated as of September 27, 2017, by and among (i) NIGHTSTAR THERAPEUTICS PLC, a public limited company incorporated under the laws of England and Wales, and its successors (the “Company”), (ii) CITIBANK, N.A., a national banking association organized under the laws of the United States of America (“Citibank”) acting in its capacity as depositary, and any successor depositary hereunder (Citibank in such capacity, the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).
DATED 12th October 2017Licence of Technology • April 3rd, 2018 • Nightstar Therapeutics PLC • Biological products, (no disgnostic substances)
• Licensee is a private biopharmaceutical company focused on the development of therapies for inherited retinal dystrophies.
